VIOLIN JONATHAN (President and COO) reported 1 transaction at VIRIDIAN THERAPEUTICS, INC.\DE
Review the transaction codes below to understand the nature of each event.
Filed: 10/30/2020ACC: 0000899243-20-029996
Officer· President and COO
Since Oct 2020
+4.40M
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
3
Total transactions
4.40M acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+50.12K
Price / share
—
Trade value
—
% of position
New position
10/27/2020
0.00→50.12K
Total
Net shares
+50.12K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/27/2020 | J · J | +50.12K | — | — | New position | 0.00 | 50.12K |
| Total | +50.12K | $0.00 | ||||||
Derivative Transactions2
Employee Stock Option (Right to Buy)
Direct
Converts to
Common Stock
4.34M shares
Shares
+4.34M
Strike price
0.01
Held after
4.34M
Exercisable
—
10/27/2020
Series A Non-Voting Convertible Preferred Stock
Direct
Converts to
Common Stock
9.41M shares
Shares
+9.41K
Strike price
Held after
9.41K
Exercisable
—
10/27/2020
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy) Direct | Common Stock4.34M shares | 10/27/2020 | J · J | +4.34M | 0.01 | — | 4.34M |
| Series A Non-Voting Convertible Preferred Stock Direct | Common Stock9.41M shares | 10/27/2020 | J · J | +9.41K | — | 9.41K |